Results 121 to 130 of about 1,804 (172)

Rapid acquisition of daptomycin resistance in a <i>Corynebacterium striatum</i> osteoarticular infection: case report and discussion on antimicrobial resistance. [PDF]

ASM Case Rep
Rezzoug I, Zamparini E, Court C, Mizrahi A, Dortet L, Emeraud C.   +5 more
europepmc   +1 more source

Direct Access to Iron Carbenes from Aldehyde, Ketone, and Formamide Feedstocks. [PDF]

J Am Chem Soc
Pedersen PS, Burton KI, Kaster SHM, Lin E, Pace AL, Bryan MC, Sodano TM, Intermaggio NE, Kelly CB, MacMillan DWC.   +9 more
europepmc   +1 more source

Oxazolidinone antibiotics impair <i>ex vivo</i> megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets. [PDF]

Antimicrob Agents Chemother
Milosevic TV, Vertenoeil G, Vainchenker W, Tulkens PM, Constantinescu SN, Van Bambeke F.   +5 more
europepmc   +1 more source

Activity of contezolid against methicillin-resistant <i>Staphylococcus aureus</i> in a rat model of foreign body osteomyelitis. [PDF]

Microbiol Spectr
Herren SC, Karau MJ, Koscianski C, Greenwood-Quaintance KE, Mandrekar JN, Wang W, Patel R.   +6 more
europepmc   +1 more source

In Vitro Activity of Imipenem/Relebactam Alone and in Combination Against Cystic Fibrosis Isolates of <i>Mycobacterium abscessus</i>. [PDF]

Antibiotics (Basel)
Sanders M, Kim SW, Shinde A, Fletcher-Williams D, Quach E, Beringer P.   +5 more
europepmc   +1 more source

Linezolid-Resistant Coagulase-Negative Staphylococci in a Tertiary Hospital: Molecular Epidemiology, Clinical Characteristics, and Outcomes. [PDF]

Infect Chemother
Rachina S, Gostev V, Pleshkov V, Karpova O, Topolyanskaya S, Melkonyan G, Gladkikh M, Zainalabidova K, Chulkova P, Sidorenko S.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An evaluation of tedizolid for the treatment of MRSA infections

Expert Opinion on Pharmacotherapy, 2018
Methicillin-resistant Staphylococcus aureus (MRSA)is a common pathogen in acute bacterial skin and soft tissue infections (ABSSSIs), nosocomial pneumonia, bacteremia, endocarditis, as well as diabetic foot, bone, and joint infections. Areas covered: This review summarizes the randomized controlled trials that evaluated the clinical efficacy of ...
William Putnam, Ronald Hall, Steven E Pass   +2 more
exaly   +3 more sources

Tedizolid (TR-701): a new oxazolidinone with enhanced potency

Expert Opinion on Investigational Drugs, 2012
Tedizolid phosphate (TR-701) is a new oxazolidinone prodrug that is transformed in the serum into the active drug tedizolid (TR-700). Tedizolid acts by inhibiting protein synthesis and has broad activity against Gram-positive pathogens, including strains that are resistant to linezolid.This review summarizes the currently available data on this new ...
Zeina Kanafani, G Ralph Corey
exaly   +3 more sources